Temperature Control With an Esophageal Cooling Device in Post Cardiac Arrest Patients

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

June 30, 2018

Study Completion Date

June 15, 2018

Conditions
Anoxic Brain InjuryCardiac Arrest
Interventions
DEVICE

Esophageal temperature control

"Insertion of the Esophageal Cooling Device (ECD) will take place as described in the product monograph. The ECD will be connected to the heat exchange unit Blanketrol Hyper-Hypothermia System® (Cincinnati Sub-Zero, Cincinnati, OH) and will be used for temperature control for a total of 36 hours. A patient target of 35°C will be set on the heat exchange unit. Once target is attained, it will be maintained for 24 hours. Slow rewarming will then be achieved by increasing the input target by 0.2°C per hour, until a target of 36.6°C is reached.~All temperature data (device, input target, and patient bladder temperature) will be captured automatically using Data Export Software® (Cincinnati Sub-Zero, Cincinnati, OH) on an external laptop connected to the external heat exchange unit."

Trial Locations (2)

N6A 5A5

University Hospital, London Health Sciences Centre, University of Western Ontario, London

N6A 5W9

Victoria Hospital, London Health Sciences Centre, University of Western Ontario, London

All Listed Sponsors
collaborator

Western University, Canada

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT02387775 - Temperature Control With an Esophageal Cooling Device in Post Cardiac Arrest Patients | Biotech Hunter | Biotech Hunter